Editorial Board — Medscape Neurology

Board Members

 

Board Member Details

Mark J. Alberts, MD
Mark J. Alberts, MD

Vice-Chair, Department of Neurology and Neurotherapeutics; UT Southwestern Medical Center, Dallas, Texas

Mark J. Alberts, MD, has disclosed the following relevant financial relationships:
Served as a director, officer, partner, employee, advisor, consultant, or trustee for: Boehringer Ingelheim Pharmaceuticals, Inc.; Cornerstone; Bristol-Myers Squibb Company; Janssen Pharmaceuticals, Inc.; Pfizer Inc.; Lundbeck inc.; Biogen
Serve(d) as a speaker or a member of a speakers bureau for: Boehringer Ingelheim Pharmaceuticals, Inc.; Cornerstone; Bristol-Myers Squibb Company; Janssen Pharmaceuticals, Inc.; Pfizer Inc.; Genentech BioOncology
Received income in an amount equal to or greater than $250 from: Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol-Myers Squibb Company; Cornerstone; Genentech BioOncology; Lundbeck, Inc.; Janssen Pharmaceuticals, Inc.; Pfizer Inc.; Biogen
Other: Athena Neuroscience (royalties)

Charles E. Argoff, MD
Charles E. Argoff, MD

Professor, Albany Medical College; Director, Comprehensive Pain Management Center, Albany Medical Center, Albany, New York

Charles E. Argoff, MD, has disclosed the following relevant financial relationships:
Served as a director, officer, partner, employee, advisor, consultant, or trustee for: Depomed; Collegium Pharmaceutical, Inc; Grunenthal Group; Astra Zeneca; Daiichi
Served as a speaker or a member of a speakers bureau for: Janssen; Allergan; Depomed; Avanir; Astra Zeneca; Daiichi
Received research grant from: Grunenthal Group; Alder Biopharmaceuticals

Jeffrey L. Cummings, MD
Jeffrey Cummings, MD

Jeffrey L. Cummings, MD, ScD, Professor of Medicine, Cleveland Clinic Lerner College of Medicine, Case Western University, Cleveland, Ohio; Adjunct Professor of Psychology, College of Liberal Arts, University of Nevada, Las Vegas; Adjunct Clinical Professor of Neurology, University of Nevada Las Vegas School of Medicine, Las Vegas, Nevada; Director, Cleveland Clinic Lou Ruvo Center for Brain Health, Camille and Larry Ruvo Chair for Brain Health, Cleveland Clinic Neurological Institute, Las Vegas, Nevada

Jeffrey L. Cummings, MD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: AbbVie; ACADIA Pharmaceuticals Inc.; Accera; Actinogen; Adamas Pharmaceuticals Corporation; Alkahest; Alzheon; Anavex; Astellas Pharma, Inc; Astra Zeneca; Avanir Pharmaceuticals; Axovant; Biogen-Idec; Biotie; Boehringer Ingelheim; Chase; Eisai Inc.; Forum; Genentech, Inc.; Grifolis; Intracellular Therapies; IRIS; Ionis Pharmaceuticals; Eli Lilly and Company; Lundbeck; Merck & Co., Inc.; Neurotrope; Novartis Pharmaceuticals Corporation; Nutricia; Otsuka Pharmaceutical Co., Ltd.; Pfizer Inc; Probiodrug; QR Pharma; Resverlogix; Roche; Servier; Sunovion; Suven Life Sciences; Takeda Pharmaceuticals North America; Toyama Chemical; Transition Therapeutics; United Neuroscience; GE Healthcare; MedAvante
Owns stock in: Adamas Pharmaceuticals Corporation; Prana; Sonexa; MedAvante, Inc.; Neurotrax; Neurokos
Received (in kind) research grant from: Avid Radiopharmaceuticals; Teva Pharmaceuticals; CogState
Owns Copyright for: Neuropsychiatric Inventory

Hans-Christoph Diener, MD, PhD

Professor, Department of Neurology, Stroke Center-Headache Center, University Duisburg-Essen, Hufelandstrasse, Essen, Germany

Hans-Christoph Diener, MD, PhD, has disclosed the following relevant financial relationships:
Received honoraria for participation in clinical trials, contribution to advisory boards or oral presentations from: Abbott; Allergan; AstraZeneca; Bayer Vital; Bristol-Myers Squibb; Boehringer Ingelheim; CoAxia; Corimmun; Covidien; Daiichi-Sankyo; D-Pharm; Fresenius; GlaxoSmithKline; Janssen Cilag; Lilly; MSD; Medtronic; MindFrame; Neurobiological Technologies; Novartis; Novo-Nordisk; Johnson & Johnson; Knoll; Paion; Parke-Davis; Pfizer Inc; sanofi-aventis; Schering-Plough; Servier; Solvay; Syngis; St. Jude; Talecris; Thrombogenics; WebMD Global; Wyeth; Yamanouchi
Received financial support for research projects from: AstraZeneca; Boehringer Ingelheim; GlaxoSmithKline; Lundbeck; Novartis; Janssen-Cilag; sanofi-aventis; Syngis; Talecris. The Department of Neurology in Essen is supported by the German Research Council (DFG), the German Ministry of Education and Research (BMBF), European Union, National Institutes of Health, Bertelsmann Foundation, and Heinz-Nixdorf Foundation. Hans-Christoph Diener, MD, PhD, has no ownership interest and does not own stocks of any pharmaceutical company.
Within the past year Dr Diener served as editor of Aktuelle Neurologie, Arzneimitteltherapie, Kopfschmerznews, Stroke News, and the Treatment Guidelines of the German Neurological Society; as co-editor of Cephalagia, and on the editorial board of Lancet Neurology, Stroke, European Neurology, and Cerebrovascular Disorders.
Serve(d) on a scientific advisory board or data safety monitoring board: Allergan; AstraZeneca; Bristol-Myers Squibb; Boehringer Ingelheim; CoAxia; Covidien; Daiichi-Sankyo; D-Pharm; GlaxoSmithKline; Medtronic; Neurobiological Technologies; Novartis; Johnson & Johnson; Pfizer Inc; sanofi-aventis; Servier; St. Jude

Randolph W. Evans, MD
Randolph W. Evans, MD

Clinical Professor, Baylor College of Medicine, Houston, Texas

Randolph W. Evans, MD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Alder; Eli Lilly and Company; Promius Pharma, LLC
Serve(d) as a speaker or a member of a speakers bureau for: Allergan, Inc.; Depomed, Inc; Pernix; Avanir Pharmaceuticals

Mark Freedman, MD
Mark Freedman, MD

Professor of Medicine (Neurology), University of Ottawa; Director, Multiple Sclerosis Research Unit, The Ottawa Hospital General Campus, Ottawa, Ontario, Canada

Mark Freedman, MD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Actelion Pharmaceuticals US, Inc; Bayer; Biogen Idec; Hoffmann-La Roche; Merck Serono Inc: Novartis; Opexa Therapeutics; Sanofi
Serve(d) as a speaker or member of a speakers bureau for: Genzyme Corporation
Received honoraria or consultation fees: Actelion Pharmaceuticals US, Inc; Bayer; Biogen Idec; Chugai Pharma USA, LLC; EMD Serono Canada: Genzyme Corporation; Novartis; Merck Serono Inc; Hoffmann-La Roche; Sanofi; Teva Canada Innovations

Sam Gandy, MD, PhD
Sam Gandy, MD, PhD

Director, Center for Cognitive Health, Mount Sinai Hospital; Professor of Neurology and Psychiatry, Mount Sinai School of Medicine, New York, New York

Sam Gandy, MD, PhD, has disclosed the following relevant financial relationships:
Received a research grant from: Baxter; Amicus Therapeutics
Received income in an amount equal to or greater than $250 from: Pfizer Inc; DiaGenic

Werner Hacke, MD, PhD, DSc
Werner Hacke, MD, PhD

Werner Hacke, MD, PhD, DSc, Senior Professor of Neurology, University of Heidelberg; Professor Emeritus; Former Head, Department of Neurology, Universitatklinikum Heidelberg, Heidelberg, Germany

Werner Hacke, MD, PhD, DSc, has disclosed the following relevant financial relationship:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Boehringer Ingelheim Pharmaceuticals, Inc.; Medtronic, Inc.; Neuravi
Serve(d) as a speaker or a member of a speakers bureau for: Boehringer Ingelheim Pharmaceuticals, Inc.
Received research grant from: Boehringer Ingelheim Pharmaceuticals, Inc.

Robert A. Hauser, MD, MBA
Robert A. Hauser, MD, MBA

Professor of Neurology, Department of Molecular Pharmacology and Physiology, University of South Florida; Director, University of South Florida Health Byrd Parkinson’s Diseases and Movement Disorders Center, Tampa, Florida

Robert Hauser, MD, MBA, has disclosed the following relevant financial relationships:
Serve(d) as a consultant for: Guidepoint Global; Gerson Lehrman Group; LCN Consulting; Putnam Associates; National Parkinson Foundation; eResearch Technology, Inc.; Lundbeck LLC; Cynapsus Therapeutics Inc.; Sarepta Therapeutics; Adamas Pharmaceuticals; Neurocrine Biosciences, Inc.; Back Bay Life Science Advisors; US WorldMeds; Biotie Therapies; The Michael J. Fox Foundation; Neuropore Therapies; National Institutes of Health; Projects In Knowledge Inc.; Prexton Therapeutics; Acorda Therapeutics; Vista Research, Inc.; LifeMax; PeerView Press; Clincial Mind: Medical and Therapeutic Communications; Sunovion Pharmaceuticals, Inc.; Academy for Continued Healthcare Learning, LLC; Outcomes Insights; ExpertConnect; HealthLogiX; Teva Pharmaceuticals USA; Cowen and Company, LLC; Pharma Two B, Ltd; Pfizer Inc.; RMEI Medical Education for Better Outcomes; ClearView Healthcare Partners; Health Advances; Kyowa Kirin Pharmaceutical Development, Ltd.; IMPAX Laboratories, Inc.; Quintiles Transnational Corp.; AbbVie Inc.; AstraZeneca Pharmaceuticals LP; Eli Lilly and Company; Decision Resources, Inc.; Seagrove Partners, LLC; Intec Pharma Ltd.; Schlesinger Associates Inc.; Huron Consulting Group; Pennside Partners, Ltd.; Bracket Global; Phase Five Communications Inc.; Windrose Consulting Group
Received research grant from: AbbVie Inc; Acorda Therapeutics; AstraZeneca Pharmaceuticals LP; Axovant Sciences, Inc.; Biogen Idec Inc.; Biotie Therapies; Civitas Therapeutics Inc.; Cynapsus Therapeutics Inc.; Sunovion Pharmaceuticals, Inc.; Enterin Inc.; IMPAX Laboratories, Inc.; Intec Pharma Ltd.; Jaz Pharmaceuticals PLC; Kyowa Pharmaceutical Inc.; NeuroDerm; Pfizer Inc.; Lundbeck LLC; Parkinson’s Progression Markers Initiative (The Michael J. Fox Foundation); Roche
Received grant support from: National Parkinson Foundation

Richard S. Isaacson, MD
Richard S. Isaacson, MD

Associate Professor, Department of Neurology, Weill Cornell Medicine, New York, New York

Richard S. Isaacson, has disclosed no relevant financial relationships.

Andres Kanner, MD
Andres Kanner, MD

Professor of Clinical Neurology, University of Miami; Staff Physician, Department of Neurology, University of Miami Hospital, Miami, Florida

Andres M. Kanner, MD, has disclosed no relevant financial relationships.

Helmi L. Lutsep, MD
Helmi L. Lutsep, MD

Professor and Vice Chair, Department of Neurology, Oregon Health & Science University; Chief of Neurology, VA Portland Health Care System, Portland, Oregon

Helmi L. Lutsep, MD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Stroke adjudication committee for CREST 2 trial and executive committee for DEFUSE 3 trial (National Institute of Neurological Disorders and Stroke); Coherex Medical; ReWalk Ro

Thomas Roth, PhD
Thomas Roth, PhD

Professor, Department of Psychiatry, Wayne State Medical School; Director, Sleep Disorders and Research Center, Henry Ford Hospital, Detroit, Michigan

Thomas Roth, PhD, has disclosed the following relevant financial relationships:
Serve(d) as a speaker or a member of the speakers bureau for: Merck & Co., Inc.; Pernix
Received an income in an amount equal to or greater than $250 from: Pfizer Inc; Flamel Technologies; Purdue Pharma L.P.; Novartis Pharmaceuticals Corporation; Actelion Pharmaceuticals, Ltd; Eisai; Merck & Co., Inc.; Pernix; Jazz Pharmaceuticals, Inc.

Stephen D. Silberstein, MD
Stephen D. Silberstein, MD

Professor, Department of Neurology, University of Pennsylvania; Director, Jefferson Headache Center, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania

Stephen D. Silberstein, MD, has disclosed the following financial relationships:
Received research grant from: Amgen Inc.; Allergan, Inc.; Eli Lilly and Company; CoLucid Pharmaceuticals Inc.; Alder Biopharmaceuticals
Serve(d) as a consultant/received honoraria from: Alder Biopharmaceuticals; Allergan, Inc.; Amgen Inc.; Avanir Pharmaceuticals; Curelator, Inc.; Depomed, Inc.; Dr. Reddy’s Laboratories; eNeura Inc.; electroCore Medical, LLC; Insys Therapeutics; Labrys Biologics, Inc.; Lilly USA, LLC; Medscape, LLC; Medtronic, Inc.; Neuralieve; National Institute of Neurological Disorders and Stroke; Pfizer Inc.; Supernus Pharmaceuticals, Inc.; Teva Pharmaceuticals USA; Theranica Ltd.; Trigemina, Inc.

Michael J. Thorpy, MD
Michael J. Thorpy, MD

Michael J. Thorpy, MD, Professor of Neurology, Albert Einstein College of Medicine; Director, Sleep-Wake Disorder Center, Montefiore Medical Center, Bronx, New York

Michael J. Thorpy, MD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Jazz Pharmaceuticals, Inc.
Serve(d) as a speaker or a member of a speakers bureau for: Jazz Pharmaceuticals, Inc.
Received research grant from: Jazz Pharmaceuticals, Inc.; Avadel Pharmaceuticals, Plc.

Lynn R. Webster, MD
Lynn R. Webster, MD

Vice President of Scientific Affairs, PRA Health Sciences, Salt Lake City, Utah

Lynn R. Webster, MD, has disclosed the following relevant financial relationships:
Serve(d) as consultant for: Egalet; Elysium Health; Insys Therapeutics; KemPharm, Inc.; Mallinckrodt Pharmaceuticals; Pain Therapeutics, Inc.; Pfizer, Inc.; Shionogi & Co., Ltd; Teva Pharmaceutical Industries Ltd.
Serve(d) on advisory board for: Daiichi Sankyo; Egalet; Teva Pharmaceutical Industries Ltd.
Received travel expenses from: Daiichi Sankyo; Depomed, Inc.; Egalet; Elysium Health; Insys Therapeutics; KemPharm, Inc.; Pfizer, Inc.; Teva Pharmaceutical Industries Ltd.

Andrew N. Wilner, MD
Andrew N. Wilner, MD

Assistant Professor, Department of Neurology, Mayo Clinic, Phoenix, Arizona

Andrew N. Wilner, MD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Accordant Health Services, a division of CVS
Serve(d) as a speaker or a member of a speakers bureau for: Pharmatecture, LLC
Received income in an amount equal to or greater than $250 from: Sermo
Received royalties from: Demos Publications; Createspace